Skip to content
Sök för att lära dig mer om InterSystems produkter och lösningar, karriärmöjligheter med mera.

Conducting Decentralized Clinical Studies

With Smart Consumer Technology, InterSystems IRIS for Health, and HL7 FHIR

father holding young son while on a telehealth call with the peditrician

Getting enough people to enroll and participate to the end of a clinical study is a major challenge. Most studies fail to enroll enough subjects to even begin. And if you can’t enroll enough people, you certainly can’t gather enough data to ensure statistically sound results.
Today, researchers are addressing these challenges by decentralizing studies – offering components of the study to the patient at home, instead of requiring participants to visit study sites. As of 2021, 48%-95% of research sites report using at least one form of decentralized technology.1

InterSystems IRIS for Health™ data platform supports decentralized and hybrid study models, enabling researchers to gather data from study participants, connected remote, wearable, or implanted medical devices, and electronic health records, health information exchanges, and other sources. Combined and transformed by InterSystems IRIS for Health into a single consistent format, such as HL7® FHIR® (FHIR), this data becomes the foundation for analysis and a comprehensive perspective on patient health and treatment effectiveness. Researchers in pharma, life sciences, and MedTech organizations can create a virtuous circle of feedback that drives continuous improvements in research, care, and outcomes.

Create a virtuous circle where device and other real-world data, aggregated, transformed, and delivered by InterSystems, helps drive continuous improvement in research, analytics, patient care and outcomes - Diagram
Create a virtuous circle where device and other real-world data, aggregated, transformed, and delivered by InterSystems, helps drive continuous improvement in research, analytics, patient care and outcomes.

Customer Use Case: Medical Device Maker

A major medical device maker conducted a decentralized study supported by InterSystems IRIS for Health data platform to gain a full, multi-dimensional view of therapy effectiveness. InterSystems IRIS for Health aggregated and transformed device, performance, time series, patient reported outcomes, and electronic health record data into FHIR format, and prepared it for access through the SQL already familiar to data scientists. Using InterSystems IRIS for Health, the data scientists gained the context they needed around the raw device data to answer critical questions using predictive and operational analytics. The platform and smart consumer technology enabled this customer to:

  • Conduct a decentralized clinical study efficiently to validate and improve device performance
  • Illuminate factors influencing variations in disease course among patients
  • Provide guidance to clinicians on personalizing patient treatment
  • Increase the value of the patient monitoring program

InterSystems IRIS for Health

InterSystems IRIS for Health can make studies more diverse and easier to participate in by gathering data from the subject at home, as well as devices and the hospital or clinic. By aggregating and normalizing diverse data types for analytics, machine learning, and AI systems, it helps researchers answer questions about treatment performance and function, track patient progress, and identify study issues before they become problems.


1 - McKinsey and Company, “No place like home? Stepping up the decentralization of clinical trials.”
https://www.mckinsey.com/industries/life-sciences/our-insights/no-place-like-home-stepping-up-the-decentralization-of-clinical-trials

Other Resources You Might Like

Nov 21, 2024
Make Your HIE Vision a Reality
Specifying Requirements, Evaluating Technologies, and Selecting Partners Download the Planning Guide
Oct 31, 2024
BLOOR Research Opinion Article
This article from UK Analyst Bloor Research recognises the capabilities and advantages of InterSystems IRIS data platform as an "innovative and powerful data management platform" and it’s Smart Data Fabric capabilities offering a market differentiator.
Oct 31, 2024
HIMSSCast
How to get the most benefit from machine learning and AI How can healthcare organizations best leverage artificial intelligence (AI) tools, including generative artificial intelligence (GenAI)? Join Alex MacLeod, Director of Healthcare Solution Innovation at InterSystems, as she discusses key steps and challenges for organizations interested in adopting AI and other advanced technologies, as well as use cases that can improve care delivery and drive operational efficiencies.
Oct 30, 2024
A Benchmarking System to Spark Companies to Action
Download the Report
Oct 23, 2024
Market Note
This report explores how advancements in AI, including large language models and natural language processing, are revolutionizing every aspect of capital markets, from trading strategies to compliance and portfolio management.
Oct 22, 2024
Fact Sheet
Unified Data has the Power to Transform
Oct 22, 2024
ISG Research
This Ventana Research Buyers Guide: Data Platforms is an assessment of how well software providers’ offerings address enterprises’ requirements for data platforms software, evaluating software in seven key categories that are weighted to reflect buyers’ needs based on expertise and research.
Oct 16, 2024
Migration Options for Application & Solution Providers
Migrating InterSystems IRIS® and InterSystems IRIS for Health™ from on-premises to the cloud offers many advantages for Application Providers and Solution Providers. These advantages include simplified operations, access to flexible resources, and enhanced resilience. Companies no longer need to worry about the physical constraints and expenses associated with maintaining on-prem infrastructure, such as power and space requirements and expensive computer hardware.
Oct 16, 2024
TabbFORUM’s Market Structure Wave
In this edition of TabbFORUM’s Market Structure Wave video series, InterSystems Irene Galperin, Senior Advisor, Financial Services, discusses how firms in the capital markets have been investing and experimenting with AI, particularly most recently with the advent of ChatGPT. In this interview, conducted by TABB Group CEO Bruce Morris, Irene offers several use cases and explains that data is at the core of implementing AI, as data needs to be "high quality and consistent," essentially "AI-ready."
Oct 10, 2024
Get Your Data AI-Ready and Simplify Development and Deployment
Unleash the power of AI in healthcare with InterSystems solutions for seamless FHIR integration and development.

Ta nästa steg

Vi vill gärna prata med dig. Fyll i några uppgifter så kontaktar vi dig.
*Obligatoriska fält
Highlighted fields are required
*Obligatoriska fält
Highlighted fields are required

Genom att skicka din kontaktinformation till InterSystems via detta formulär bekräftar och godkänner du att InterSystems kan behandla denna information, i syfte att uppfylla din förfrågan, via ett system som finns i USA, men som upprätthålls i enlighet med alla tillämpliga dataskyddslagar.



** Genom att välja ja ger du ditt samtycke till att bli kontaktad för nyheter, uppdateringar och andra marknadsföringsändamål i samband med befintliga och framtida InterSystems produkter och evenemang. Dessutom samtycker du till att dina kontaktuppgifter för företaget förs in i vår CRM-lösning som finns i USA, men som upprätthålls i enlighet med gällande dataskyddslagar.